Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8323 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.828 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8272 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8261 |
Intermediate Similarity |
NPD1091 |
Approved |
0.8252 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8235 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8207 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8207 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.8138 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8138 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8112 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8054 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7988 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7947 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7939 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7937 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7892 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7877 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7872 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7862 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7844 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7842 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7808 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7799 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7799 |
Intermediate Similarity |
NPD37 |
Approved |
0.7798 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7793 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.777 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7764 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7764 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7764 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7764 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.775 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7736 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7736 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7683 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7677 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7665 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.764 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7635 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7595 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7588 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7568 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7545 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7529 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD4536 |
Approved |
0.75 |
Intermediate Similarity |
NPD4538 |
Approved |
0.75 |
Intermediate Similarity |
NPD8312 |
Approved |
0.75 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD8313 |
Approved |
0.75 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7468 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7468 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7451 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7439 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7436 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7432 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7423 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7419 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7405 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7405 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7405 |
Intermediate Similarity |
NPD6799 |
Approved |
0.74 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7372 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7358 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7338 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7338 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7337 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7308 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7286 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7286 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7279 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7273 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7262 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7255 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.725 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7244 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7244 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7239 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.723 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7219 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7215 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7181 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7178 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7174 |
Intermediate Similarity |
NPD290 |
Approved |
0.7166 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7158 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD4433 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7134 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7134 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7133 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7125 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7125 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7124 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7123 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7123 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7119 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7108 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7105 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7101 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7097 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7074 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7073 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.707 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.707 |
Intermediate Similarity |
NPD4477 |
Approved |
0.707 |
Intermediate Similarity |
NPD4476 |
Approved |
0.707 |
Intermediate Similarity |
NPD2796 |
Approved |
0.707 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7055 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7052 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD3536 |
Discontinued |
0.7018 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7016 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7016 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7007 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7007 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD4535 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD4666 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.6994 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6989 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6975 |
Remote Similarity |
NPD1511 |
Approved |
0.6974 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.697 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD1240 |
Approved |
0.6968 |
Remote Similarity |
NPD4140 |
Approved |
0.6962 |
Remote Similarity |
NPD6099 |
Approved |
0.6962 |
Remote Similarity |
NPD6100 |
Approved |
0.6962 |
Remote Similarity |
NPD6032 |
Approved |
0.6957 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6949 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6948 |
Remote Similarity |
NPD1296 |
Phase 2 |
0.6944 |
Remote Similarity |
NPD6842 |
Approved |
0.6944 |
Remote Similarity |
NPD6841 |
Approved |
0.6944 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6941 |
Remote Similarity |
NPD5709 |
Phase 3 |
0.6933 |
Remote Similarity |
NPD3685 |
Discontinued |
0.6928 |
Remote Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD1933 |
Approved |
0.6923 |
Remote Similarity |
NPD3882 |
Suspended |
0.6915 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6913 |
Remote Similarity |
NPD1535 |
Discovery |
0.6908 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6899 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6897 |
Remote Similarity |
NPD6671 |
Approved |
0.6892 |
Remote Similarity |
NPD4626 |
Approved |
0.689 |
Remote Similarity |
NPD1512 |
Approved |
0.6882 |
Remote Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD3749 |
Approved |
0.6879 |
Remote Similarity |
NPD6653 |
Approved |
0.6879 |
Remote Similarity |
NPD1607 |
Approved |
0.6871 |
Remote Similarity |
NPD1894 |
Discontinued |
0.6867 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.6857 |
Remote Similarity |
NPD968 |
Approved |
0.6852 |
Remote Similarity |
NPD6190 |
Approved |
0.6848 |
Remote Similarity |
NPD7427 |
Discontinued |
0.6846 |
Remote Similarity |
NPD3847 |
Discontinued |
0.6845 |
Remote Similarity |
NPD6777 |
Approved |
0.6845 |
Remote Similarity |
NPD6781 |
Approved |
0.6845 |
Remote Similarity |
NPD6779 |
Approved |
0.6845
|
Remote Similarity |
NPD6776 |
Approved |